SUMMIT SECURITIES GROUP LLC - SYNAGEVA BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
SUMMIT SECURITIES GROUP LLC ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q4 2014$9,000
+50.0%
1000.0%0.00%
+50.0%
Q3 2013$6,000
-72.7%
100
-80.4%
0.00%
-80.0%
Q2 2013$22,000–510–0.01%–
 Download
Other shareholders

There were no reported owners of SYNAGEVA BIOPHARMA CORP in Q4 2013.

NameSharesValueWeighting ↓
View complete list of SYNAGEVA BIOPHARMA CORP shareholders